close
Add to watchlist
Pure Bioscience (PURE) Capital Goods
PURE Bioscience engages in the development, production, sale, and licensing of silver ion bioscience technologies and boric acid based pesticides principally in the United States. The company offers silver dihydrogen citrate-based antimicrobials and boric acid-based pesticides. The silver dihydrogen citrate technology is an electrolytically generated source of stabilized ionic silver that would serve as the basis for various products in diverse markets. It also provides Axen and Axen30 hard surface disinfectant products for commercial, industrial, and consumer applications, including restaurants, homes, and medical facilities. PURE Bioscience sells its products to retail, commercial, and institutional customers through distributors. The company, formerly known as Innovative Medical Services, was founded in 1992 and is headquartered in El Cajon, California.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 0.37 |
| Volume | 227639 |
| Volume Avg | 211427 |
| 52 Week High | 1.85 |
| 52 Week Low | 0.32 |
| PE | N/A |
| PE (group average) | 38 |
| EPS Year | -0.23 |
| EPS change Q/Q | -16.67% |
| EPS change Q/Q Yr ago | -40% |
| EPS change Q/Q next Q est | 100% |
| EPS change Y/Y | -13.04% |
| REV change Q/Q | -100% |
| REV change Q/Q Yr ago | -66.67% |
| EPS next Q est | 0.00 |
| EPS next Y est | 0.00 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |